phl-desipramine tablet
pharmel inc - desipramine hydrochloride - tablet - 75mg - desipramine hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors
phl-desipramine tablet
pharmel inc - desipramine hydrochloride - tablet - 100mg - desipramine hydrochloride 100mg - tricyclics and other norepinephrine-reuptake inhibitors
desipramine hydrochloride tablet film coated
avera mckennan hospital - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg
desipramine hydrochloride tablet film coated
bryant ranch prepack - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 25 mg
desipramine hydrochloride tablet film coated
kaiser foundation hospitals - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg
norpramin- desipramine hydrochloride tablet, sugar coated
sanofi-aventis u.s. llc - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - norpramin is indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with norpramin or within 14 days of stopping treatment with norpramin is contraindicated because of an increased risk of serotonin syndrome. the use of norpramin within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration). starting norpramin in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration). norpramin is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.
norpramin- desipramine hydrochloride tablet, sugar coated
validus pharmaceuticals llc - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - norpramin is indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with norpramin or within 14 days of stopping treatment with norpramin is contraindicated because of an increased risk of serotonin syndrome. the use of norpramin within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( s ee warnings and dosage and administration ). starting norpramin in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). norpramin is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.
ratio-desipramine tab 75mg tablet
ratiopharm inc division of teva canada limited - desipramine hydrochloride - tablet - 75mg - desipramine hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors
ratio-desipramine tab 50mg tablet
ratiopharm inc division of teva canada limited - desipramine hydrochloride - tablet - 50mg - desipramine hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors
ratio-desipramine tab 25mg tablet
ratiopharm inc division of teva canada limited - desipramine hydrochloride - tablet - 25mg - desipramine hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors